eHealth, Inc. (EHTH) Company Overview

eHealth, Inc. is a Nasdaq-listed health-insurance distributor operating under ticker EHTH. It does not underwrite insurance or take medical risk. Instead, its marketplace, licensed advisors, ecommerce tools, and post-enrollment services help consumers compare and enroll in carrier plans. Its stated mission—guiding consumers “when, where and how they prefer”—summarizes the hybrid online-and-telephone model. Readers can see the consumer-facing proposition on the official eHealth marketplace.

Which customers and products define the company?

The Medicare segment sells Medicare Advantage, Supplement, Part D, and related ancillary coverage. Employer and Individual serves individual, family, small-business, ICHRA, dental, vision, short-term, and hospital-indemnity buyers. The result is a regulated distribution and customer-acquisition business, not conventional software.

Most revenue comes from carrier commissions. When eHealth becomes broker of record on an approved application, it recognizes constrained lifetime commission value under ASC 606 and collects cash over time. Medicare Advantage and Part D can pay initial annual and later monthly commissions; other products generally pay per member or as a share of premium.

What revenue streams sit beyond broker commissions?

The company also earns advertising, technology-licensing, captive-agent, non-broker enrollment, and post-enrollment service fees. These streams can reduce dependence on the broker-of-record model. The FY2025 Form 10-K reported $498.0M of commission revenue and $56.1M of other revenue, or roughly 89.9% and 10.1% of total revenue, respectively.

Volume alone is not enough. eHealth can enroll fewer members yet improve economics when commission value rises and acquisition cost falls faster than revenue. In early 2026, management cut lower-return channels, accepted lower enrollment, and emphasized higher-quality demand.

What changed in Medicare economics?

The Q1 2026 earnings package showed Medicare Advantage constrained LTV of $938, Medicare Supplement LTV of $1,494, and Medicare Part D LTV of $298. Total acquisition cost per MA-equivalent approved member fell 10% to $676, because variable marketing cost dropped to $283 even as customer-care and enrollment cost rose to $393. These figures are detailed in the Q1 2026 earnings presentation.

The latest official period available is the quarter ended March 31, 2026. Revenue fell sharply because management reduced acquisition spending and approved-member volume, but the company protected adjusted profitability by cutting variable marketing and fixed costs. The result is a business that looks smaller on the top line but more disciplined at the segment level.

How did revenue, expenses, and profitability move?

What is management guiding for FY2026?

In the May 6, 2026 earnings release, management reiterated full-year guidance of $405M-$445M of revenue, $8M-$25M of GAAP net income, $55M-$75M of adjusted EBITDA, and operating cash flow between $(10)M and $12M. The range assumes $8M-$20M of positive net adjustment revenue. The wide cash-flow range underscores how collections and acquisition timing can differ from reported earnings.

eHealth’s history matters because today’s company is the product of several shifts: from early online insurance commerce to Medicare specialization, from growth spending to preferred-capital constraints, and from enrollment volume toward lifetime advisory and channel profitability.

1. 1997
   The company was incorporated in Delaware and built one of the first internet-based health-insurance purchasing models. This origin still supports its digital distribution identity.
2. 2006
   eHealth completed its IPO and began trading on Nasdaq, giving the company public-market capital for platform and distribution expansion.
3. 2021
   H.I.G.’s Echelon vehicle invested $225M in Series A preferred stock. That financing later became a major governance, dividend, and redemption consideration.
4. 2023-2024
   The company failed the preferred investment’s minimum asset-coverage test in September 2023, and a H.I.G. board observer was appointed in March 2024. Capital structure began to influence strategic freedom more visibly.
5. 2024
   Some Medicare Supplement broker-of-record arrangements shifted to fee-based arrangements in the Amplify platform, signaling an effort to diversify monetization.
6. 2025
   Derrick Duke succeeded Francis Soistman as CEO in September. In December, eHealth entered a new revolving credit facility and amended H.I.G. governance and liquidity terms.
7. 2026
   A roughly 14% workforce reduction, lower marketing intensity, lifetime advisory initiatives, and a final-expense offering marked a shift toward efficiency and member-value expansion.

Why does the 2025-2026 reset matter most?

The reset changes the valuation question. The current test is whether eHealth can preserve profitable acquisition channels, convert receivables into cash, and reduce fixed costs fast enough to absorb lower revenue. Execution matters more than a simple rebound in approved-member counts. The current management roster is available on the official executive-management page.

eHealth’s advantage is not a single patent or network effect. It combines regulated distribution, long-standing carrier relationships, licensed advisors, enrollment data, digital shopping tools, and omnichannel support. Together, those assets can improve matching and conversion while giving carriers a scalable route to consumers.

Who competes with eHealth?

The filing identifies government marketplaces, Original Medicare, direct-selling carriers, local agents, large Medicare platforms, ICHRA administrators, benefits platforms, and lead generators. Rivalry is intense because many compete for the same consumer attention, while carriers both supply eHealth and sell directly.

eHealth’s balance sheet is unusual because commissions receivable dominate assets. At March 31, 2026, current and non-current commissions receivable totaled approximately $1.04B, compared with $110.8M of cash, cash equivalents, and short-term securities. That receivable base supports future collections, but it also embeds assumptions about member retention, commission rates, carrier payment, and cohort performance.

Why can profit and cash flow move in opposite directions?

eHealth recognizes expected lifetime commissions when policies are approved, while related acquisition costs are incurred near enrollment and cash commissions arrive over later periods. Consequently, a growth year can consume cash as commissions receivable expands, while a lower-enrollment quarter can release cash as old receivables are collected. The Q1 2026 Form 10-Q shows this clearly: operating cash flow was $35.8M, helped by an $86.4M decrease in contract assets, even though the quarter reported a GAAP net loss.

The preferred stock is the main balance-sheet complication. It carries cumulative dividends, accretes toward redemption value, ranks ahead of common equity, and can be put for redemption beginning in April 2027 under specified terms. At December 31, 2025, its carrying value was $382.1M and estimated redemption value was $416.3M. This claim must be treated separately from ordinary debt in any enterprise-to-equity valuation bridge.

eHealth has common stock plus a voting Series A preferred security. The latest 2026 proxy statement used an April 20, 2026 record date with 31,532,924 common shares and 2,250,000 Series A preferred shares outstanding. Common holders had one vote per share, while the H.I.G.-affiliated preferred holder had 4,425,692 votes.

Which holders have meaningful influence?

How should researchers interpret the preferred security?

The preferred investment was originally a capital solution, but it now creates a layered governance structure. H.I.G. can nominate a director while ownership thresholds are met, has additional rights linked to covenant conditions, and holds a senior claim with an 8% annual dividend structure after June 2023, split between paid-in-kind and cash components under the disclosed terms. For common shareholders, reported net income is therefore not the same as income available to common equity.

eHealth’s opportunity is not simply to buy more leads. The higher-quality path is to widen lifetime value, add fee-based services, improve retention, and lower service cost. Lifetime advisory, ePerks, MatchMonitor, advisor automation, final-expense insurance, Medicare Supplement, ICHRA, and post-enrollment services all aim to monetize the relationship beyond one enrollment.

What would confirm successful execution?

A credible improvement would combine stable Medicare gross profit, stronger LTV-to-CAC, positive full-cycle cash conversion, and less dependence on adjustment revenue. Employer and Individual would also grow selectively without recreating high acquisition costs.

The central risks are revenue estimation, carrier concentration, regulation, and capital structure. Humana, UnitedHealthcare, and Aetna represented 33%, 28%, and 13% of commissions receivable and accounts receivable at December 31, 2025. Together, those three carriers accounted for 74% of the balance, so changes in carrier contracts or member retention can affect both revenue and the value of a major asset.

Which filing risks deserve the closest attention?

The latest filing also shows that the company eliminated about 14% of its workforce in Q1 2026. Cost reduction can improve margins, but it creates execution risk if advisor capacity, technology delivery, compliance, or customer service deteriorates during key enrollment periods. That is why gross profit per member and service quality should be evaluated together.

A revenue multiple can miss eHealth’s core economics. Revenue includes future commission estimates, cash conversion can lag, and preferred claims rank ahead of common shareholders. A DCF therefore needs explicit assumptions for member volume, LTV, acquisition cost, retention, collections, cost savings, debt, and preferred redemption.

Which KPIs belong in a DCF sensitivity table?

• Medicare LTV-to-CAC: a small change can materially alter the value created by each enrollment cohort.
• Medicare segment gross margin: Q1 2026’s 41% level shows the benefit of lower variable marketing, but sustainability matters more than one quarter.
• Receivable collections: the pace at which the $1.04B asset converts to cash affects liquidity and terminal value.
• Preferred value: carrying value, cash/PIK dividends, and 2027 redemption rights can dominate common-equity outcomes.
• Adjustment revenue: a model should separate recurring enrollment economics from favorable or unfavorable changes to prior cohorts.

The annual reports, proxy materials, and quarterly filings needed for those assumptions are collected on eHealth’s annual reports and proxy page and official SEC filings page.

What is the key takeaway from eHealth analysis?